SOMERSET THERAPEUTICS LLC: Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for: Somerset
Read the official notice at FDA (drug) →
Get alerts for Somerset Therapeutics
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- SOMERSET THERAPEUTICS LLC
- Product
- Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873, NDC carton: 70069-025-10; NDC vial: 70069-025-01
- Reason / hazard
- Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Nationwide in the USA
- Recall initiated
- 2026-02-04
- Code info
- Lot #: A240421, Exp 07/31/2026
- Product quantity
- 62190 vials
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Somerset
- State
- NJ
- Country
- United States
- Event id
- 98388
Free daily digest + "My products" watchlist